UBFD1P1

Across TCGA pan-cancer cohorts, UBFD1P1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated UBFD1P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher UBFD1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBFD1P1 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

SKCM, HNSC, and KIRC are the cancer types where UBFD1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	III,IV	0.266	0.710	<.001	33	view →
HNSC	DFS	Tertile	III,IV	0.143	0.616	.006	27	view →
KIRC	OS	Tertile	II,III,IV	0.472	0.727	.025	12	view →
STAD	OS	Tertile	All	0.101	0.543	.024	9	view →
THCA	DFS	Tertile	All	0.573	0.868	.020	9	view →
LUSC	OS	Tertile	III,IV	0.977	0.279	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

UBFD1P1–SKCM (OS)

Open the SKCM breakdown →